Botulinum toxin-responsive oromandibular dystonia in cerebrotendinous xanthomatosis

Parkinsonism Relat Disord. 2011 Aug;17(7):570-2. doi: 10.1016/j.parkreldis.2011.04.006. Epub 2011 Apr 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / therapeutic use*
  • Cholestanetriol 26-Monooxygenase / genetics
  • Dystonia / drug therapy*
  • Dystonia / etiology*
  • Humans
  • Male
  • Mandible / drug effects
  • Mouth / drug effects
  • Neuromuscular Agents / therapeutic use*
  • Tomography, Emission-Computed, Single-Photon
  • Xanthomatosis, Cerebrotendinous / complications*
  • Xanthomatosis, Cerebrotendinous / drug therapy
  • Xanthomatosis, Cerebrotendinous / physiopathology

Substances

  • Neuromuscular Agents
  • CYP27A1 protein, human
  • Cholestanetriol 26-Monooxygenase
  • Botulinum Toxins, Type A